Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ABBV
ABBV logo

ABBV News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

ABBV News

Dividend Stocks Comparison: Johnson & Johnson vs. AbbVie

2d agoFool

Analysis of IVV ETF's 52-Week Price Fluctuations

2d agoNASDAQ.COM

High Dividend Stocks Investors Should Focus On

3d agoFool

AbbVie and Realty Income's Stable Dividend Prospects

3d agoNASDAQ.COM

Apple, Amazon, and TSMC Deliver Earnings Triple Plays

3d agoNewsfilter

Three High-Yield Stocks for Monthly Dividends

3d agoFool

Analysis of High-Yield Stock Investment Strategies

3d agoNASDAQ.COM

AbbVie Presents New Data at Digestive Disease Week 2026

3d agoPRnewswire

ABBV Events

04/30 16:30
Dow Rises 790.33 Points, Nasdaq Gains 219.07 Points
The major averages closed broadly higher to cap of a strong performance in April. The spotlight remains on technology after mega-cap results reinforced the strength of AI-driven demand, with traders also eyeing Apple's quarterly report after the close.Looking to data, the Commerce Department reported that GDP increased at a 2% annualized pace in Q1, up from 0.5% in the previous quarter but below market expectations of 2.3%, according to a preliminary estimate.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Alphabetreported, increased its dividend 5%, and increased its FY26 capital expenditure guidanceMeta Platformsreported, with family DAP reaching an average of 3.56B in MarchAmazonreportedand provided upbeat Q2 revenue guidanceMicrosoftreported, with Cloud revenue up 29% year-over-yearCaterpillaralso reportedand guided for low-double digit FY26 revenue growth2. WALL STREET CALLS:JPMorganMetaon lack of AI product visibilityQualcommto Buy from Hold at Summit InsightsEtsyto Neutral from Buy at B. RileyAbbVieto Buy at BofA on durable growthOppenheimeron Palantir, initiated with an Outperform3. AROUND THE WEB:MetaCEO Mark Zuckerberg and AppleCEO Tim Cook are not planning to make offers for the NFL's Seattle Seahawks, refuting earlier reporting, Bloomberg saysStrong demand for Nvidia'sB300 servers in China has doubled its prices, with the equipment costing about $1M each, Reuters reportsApplehas told suppliers that it will maintain its current production share in India rather than expand, after local sites struggled without China-based teams, Nikkei Asia reportsSoftBankplans to create an AI and robotics company called Roze in the U.S. to build data centers and list it as early as 2026, seeking a $100B valuation, Nikkei Asia saysKKRis exploring the sale of Flora Food Group, the business carved out of Unilever, after increased dairy demand has led the company to abandon a plan to make its entire portfolio plant based, FT says4. MOVERS:Everspin Technologiesgained afterfor Mil-Aero MRAM applicationsVistance Networksincreased after, announcing a $100M share repurchase program, and agreeing to sell RUCKUS to Belden for $1.846BBandwidthand Novocurewere higher in New York afterOption Care Healthand Acadia Healthcarewere lower afterWaystarfell afterand providing guidance for FY265. EARNINGS/GUIDANCE:Eli Lillyand raised its guidance for FY26Illinois Tool Works, with CEO commenting on "a solid start to the year"Newmarkand raised its guidance for FY26Melco Resorts, with EPS missing consensusCheck Pointand provided guidance for Q2 and FY26INDEXES:The Dow rose 790.33, or 1.62%, to 49,652.14, the Nasdaq gained 219.07, or 0.89%, to 24,892.31, and the S&P 500 advanced 73.06, or 1.02%, to 7,209.01.

ABBV Monitor News

AbbVie Reports Strong Quarterly Earnings Driven by Immunology Drugs

Apr 30 2026

AbbVie Reports Strong Earnings Amid Humira Sales Decline

Apr 29 2026

AbbVie reports strong revenue growth amid market volatility

Mar 18 2026

AbbVie Sues HHS Over Medicare Drug Pricing Decision

Feb 13 2026

AbbVie Submits Upadacitinib for Vitiligo Treatment Approval

Feb 04 2026

AbbVie gains on Health Canada approval for MAVIRET

Jan 07 2026

AbbVie stock declines as it hits a 20-day low

Jan 05 2026

ABBV Earnings Analysis

AbbVie Q1 2025: Strong Results & Higher EPS Guidance- Intellectia AI™
1 years ago
AbbVie's Transformative Year - Intellectia AI™
1 years ago
Earnings Summary AbbVie Reports ThirdQuarter Financial Results for 2024
1 years ago

People Also Watch